0 Bedömningar
ID

31865

Beskrivning

Study ID: 105229 Clinical Study ID: GLP105229 Study Title: A double-blinded, randomized, placebo-controlled, staggered-parallel, escalating dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous injections of GSK 716155 in healthy volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Nyckelord

Versioner (1)
  1. 2018-10-05 2018-10-05 -
Rättsinnehavare

GlaxoSmithCline

Uppladdad den

5 oktober 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Subcutaneous injections of GSK 716155 in healthy volunteers; Study ID: 105229

    Engelsk

    Study Conclusion

    1 Formulär  
    1. StudyEvent: ODM
      1. Study Conclusion
    Study Conclusion
    Beskrivning

    Study Conclusion

    Alias
    UMLS CUI-1
    C1707478
    UMLS CUI-2
    C0008976
    Study Conclusion
    Beskrivning

    Study Conclusion

    Alias
    UMLS CUI-1
    C1707478
    UMLS CUI-2
    C0008976
    Date of subject completion or withdrawal
    Beskrivning

    Study End Date; Patient withdrawn from study, date in time

    Datatyp

    date

    Alias
    UMLS CUI [1]
    C2983670
    UMLS CUI [2,1]
    C0422727
    UMLS CUI [2,2]
    C0011008
    Was the subject withdrawn from the study?
    Beskrivning

    Patient withdrawn from trial

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C0422727
    Primary reason for withdrawal
    Beskrivning

    Patient withdrawn from study; Indication

    Datatyp

    text

    Alias
    UMLS CUI [1,1]
    C0422727
    UMLS CUI [1,2]
    C0392360
    Tillbaka till toppen

    Similar models

    Study Conclusion

    1 Formulär
    1. StudyEvent: ODM
      1. Study Conclusion
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    Study Conclusion
    C1707478 (UMLS CUI-1)
    C0008976 (UMLS CUI-2)
    Item Group
    Study Conclusion
    C1707478 (UMLS CUI-1)
    C0008976 (UMLS CUI-2)
    Study End Date; Patient withdrawn from study, date in time
    Item
    Date of subject completion or withdrawal
    date
    C2983670 (UMLS CUI [1])
    C0422727 (UMLS CUI [2,1])
    C0011008 (UMLS CUI [2,2])
    Patient withdrawn from trial
    Item
    Was the subject withdrawn from the study?
    boolean
    C0422727 (UMLS CUI [1])
    Item
    Primary reason for withdrawal
    text
    C0422727 (UMLS CUI [1,1])
    C0392360 (UMLS CUI [1,2])
    Patient withdrawn from study; Indication
    Code List
    Primary reason for withdrawal
    CL Item
    Adverse event (Adverse event)
    CL Item
    Lost to follow-up (Lost to follow-up)
    CL Item
    Protocol violation (Protocol violation)
    CL Item
    Subject decided to withdraw from the study (Subject decided to withdraw from the study)
    CL Item
    Sponsor terminated study (Sponsor terminated study)
    CL Item
    Hypoglycaemic event (Hypoglycaemic event)
    CL Item
    Other, specify (Other, specify)
    Tillbaka till toppen 

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial